We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+21.29%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$876M
AUM Growth
+$149M
Cap. Flow
+$49.5M
Cap. Flow %
5.66%
Top 10 Hldgs %
74.66%
Holding
31
New
6
Increased
6
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
RPRX
Repros Therapeutics Inc.
RPRX
+$24M
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$10.3M
3
ECYT
Endocyte, Inc. Common Stock
ECYT
+$9.71M
4
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$7.27M
5
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
+$6.46M

Top Sells

Rank Stock Value
1
THOR
THORATEC CORPORATION
THOR
+$11.3M
2
GTIV
GENTIVA HEALTH SERVICES INC
GTIV
+$7.67M
3
MAKO
MAKO SURGICAL CORP COM
MAKO
+$4.54M
4
TSRO
TESARO, Inc.
TSRO
+$4.23M
5
OPK icon
Opko Health
OPK
+$1.46M

Sector Composition

Rank Sector Weight
1 Healthcare 73.01%
2 Consumer Staples 0.25%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$104M 11.9%
477,805
+2,946
+0.6% +$437K
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$88.9M 10.16%
3,256,957
-8,500
-0.3% -$248K
THC icon
3
Tenet Healthcare
THC
$22.6B
$75.2M 8.59%
1,755,950
– –
ACOR
4
DELISTED
Acorda Therapeutics
ACOR
$74.2M 8.47%
16,303
– –
MZOR
5
DELISTED
Mazor Robotics Ltd.
MZOR
$65.3M 7.46%
3,194,562
-18,712
-0.6% -$447K
THOR
6
DELISTED
THORATEC CORPORATION
THOR
$62.9M 7.18%
1,756,204
-316,496
-15% -$11.3M
OPK icon
7
Opko Health
OPK
$1.25B
$51.9M 5.93%
5,571,960
-166,782
-3% -$1.46M
HNSN
8
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$51.1M 5.84%
1,965,815
+324,072
+20% +$7.27M
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
$45.9M 5.24%
3,599,192
+189,125
+6% +$2.47M
TTHI
10
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$34.2M 3.9%
4,287,412
– –
ARAY icon
11
Accuray
ARAY
$29M
$31.1M 3.55%
3,240,006
– –
IRWD icon
12
Ironwood Pharmaceuticals
IRWD
$626M
$22.7M 2.6%
2,204,130
+913,410
+71% +$10.3M
RPRX
13
DELISTED
Repros Therapeutics Inc.
RPRX
$22M 2.52%
+1,242,326
New +$24M
VRML
14
DELISTED
Vermillion, Inc.
VRML
$21.1M 2.41%
7,139,960
– –
TSRO
15
DELISTED
TESARO, Inc.
TSRO
$18.7M 2.13%
633,752
-134,467
-18% -$4.23M
ECYT
16
DELISTED
Endocyte, Inc. Common Stock
ECYT
$16M 1.82%
+670,000
New +$9.71M
BIOL
17
DELISTED
Biolase, Inc.
BIOL
$14.8M 1.69%
491
+166
+51% +$5.79M
PGEN icon
18
Precigen
PGEN
$1.97B
$14.5M 1.65%
575,483
-11,995
-2% -$332K
PACB icon
19
Pacific Biosciences
PACB
$432M
$13.8M 1.57%
2,575,729
– –
WBMD
20
DELISTED
WebMD Health Corp.
WBMD
$12.4M 1.42%
300,141
– –
GTIV
21
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$7.73M 0.88%
847,600
-724,798
-46% -$7.67M
DSCI
22
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$6.34M 0.72%
+500,000
New +$6.46M
AMRN
23
Amarin Corp
AMRN
$293M
$5.43M 0.62%
+150,000
New +$5.58M
AGEN
24
Agenus
AGEN
$275M
$4.36M 0.5%
70,089
+7,643
+12% +$531K
AGIO icon
25
Agios Pharmaceuticals
AGIO
$2.14B
$3.92M 0.45%
+100,000
New +$3.35M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2014 Portfolio in Review

As of Q1 2014, Oracle Investment Management held 31 positions worth $876M, up 21% from $726M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Oracle Investment Management deployed $49.5M of net new capital in Q1 2014, opening 6 new positions and adding to 6 existing holdings. Its largest new stake was Repros Therapeutics Inc.: 1,242,326 shares worth $22M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 68% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was THORATEC CORPORATION, an estimated $11.3M trimmed.

  • Oracle Investment Management's largest Q1 2014 buy was Repros Therapeutics Inc.: 1,242,326 shares worth $22M.
  • Oracle Investment Management added most to Ironwood Pharmaceuticals in Q1 2014, an estimated $10.3M increase.
  • Oracle Investment Management's biggest Q1 2014 reduction was THORATEC CORPORATION, cutting an estimated $11.3M.
  • Oracle Investment Management fully exited MAKO SURGICAL CORP COM in Q1 2014, selling an estimated $4.54M.
  • Oracle Investment Management's ten largest holdings make up 75% of its $876M portfolio in Q1 2014.
  • Oracle Investment Management opened 6 new positions and closed 1 in Q1 2014.
  • Oracle Investment Management's portfolio value rose 21% quarter-over-quarter to $876M.

Based on Oracle Investment Management's 13F filing for Q1 2014, filed 15 May 2014.